Site Announcement
For the latest results and update on CytoDyn’s Phase 2 CRC trial and more, here’s a link to our April 30, 2026 investor update webinar
| Date | Form | Description | XBRL | Pages | |
|---|---|---|---|---|---|
| 12/06/17 | SC TO-I/A | Issuer tender offer statement |
|
4 | |
| 12/06/17 | 8-K | Current report filing |
|
21 | |
| 11/27/17 | SC TO-I/A | Issuer tender offer statement |
|
4 | |
| 11/27/17 | 8-K | Current report filing |
|
3 | |
| 11/24/17 | SC TO-I | Issuer tender offer statement |
|
54 | |
| 11/16/17 | D | Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act. |
|
6 | |
| 11/08/17 | 8-K | Current report filing |
|
35 | |
| 11/08/17 | 4 | Statement of changes in beneficial ownership of securities |
|
2 | |
| 11/02/17 | 8-K | Current report filing |
|
3 | |
| 10/13/17 | 8-K | Current report filing |
|
7 |
